Circulating Metabolites as Potential Biomarkers for Neurological Disorders—Metabolites in Neurological Disorders

There are, still, limitations to predicting the occurrence and prognosis of neurological disorders. Biomarkers are molecules that can change in different conditions, a feature that makes them potential tools to improve the diagnosis of disease, establish a prognosis, and monitor treatments. Metaboli...

Descripció completa

Dades bibliogràfiques

Autors principals:	Amanda Donatti, Amanda M. Canto, Alexandre B. Godoi, Douglas C. da Rosa, Iscia Lopes-Cendes
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2020-09-01
Col·lecció:	Metabolites
Matèries:	amyotrophic lateral sclerosis Alzheimer’s disease epilepsy multiple sclerosis Parkinson’s disease stroke
Accés en línia:	https://www.mdpi.com/2218-1989/10/10/389
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!